MedPath

Cefazolin

CEFAZOLIN FOR INJECTION, USP

Approved
Approval ID

c24e604f-16ca-4945-8e9d-277cc67a8c68

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 25, 2022

Manufacturers
FDA

Civica, Inc.

DUNS: 081373942

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefazolin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72572-056
Application NumberANDA065143
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefazolin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 25, 2022
FDA Product Classification

INGREDIENTS (1)

CEFAZOLIN SODIUMActive
Quantity: 10 g in 1 1
Code: P380M0454Z
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefazolin - FDA Drug Approval Details